vs
ACCESS Newswire Inc.（ACCS）与Arcus Biosciences, Inc.（RCUS）财务数据对比。点击上方公司名可切换其他公司
Arcus Biosciences, Inc.的季度营收约是ACCESS Newswire Inc.的1.9倍（$11.0M vs $5.8M），ACCESS Newswire Inc.净利率更高（-9.9% vs -963.6%，领先953.7%），ACCESS Newswire Inc.同比增速更快（-0.5% vs -52.2%），过去两年Arcus Biosciences, Inc.的营收复合增速更高（4.9% vs 2.0%）
ACCESS通讯社是一家新闻通稿分发服务商，总部位于芝加哥，1954年成立，最初通过电传设备为企业向新闻机构电子传输新闻稿，创始人赫伯特·穆舍勒曾在曼哈顿家中运营该业务长达15年，公司几经转手后，于2015年被Cision集团宣布收购。
Arcus Biosciences是一家处于临床阶段的美国基因编辑上市企业，总部位于北卡罗来纳州达勒姆，成立于2006年。公司依托其专有的“ARCUS”基因组编辑平台，专注于开发体内及体外基因编辑疗法，为相关疾病治疗提供创新解决方案。
ACCS vs RCUS — 直观对比
营收规模更大
RCUS
是对方的1.9倍
$5.8M
营收增速更快
ACCS
高出51.7%
-52.2%
净利率更高
ACCS
高出953.7%
-963.6%
两年增速更快
RCUS
近两年复合增速
2.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.8M | $11.0M |
| 净利润 | $-576.0K | $-106.0M |
| 毛利率 | 77.4% | — |
| 营业利润率 | -13.1% | -1036.4% |
| 净利率 | -9.9% | -963.6% |
| 营收同比 | -0.5% | -52.2% |
| 净利润同比 | 94.4% | -12.8% |
| 每股收益（稀释后） | $-0.16 | $-0.88 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACCSRCUS
| Q4 25 | $5.8M | $11.0M | ||
| Q3 25 | $5.7M | $6.0M | ||
| Q2 25 | $5.6M | $8.0M | ||
| Q1 25 | $5.5M | $8.0M | ||
| Q4 24 | $5.8M | $23.0M | ||
| Q3 24 | $5.6M | $7.0M | ||
| Q2 24 | $6.0M | $11.0M | ||
| Q1 24 | $5.6M | $10.0M |
净利润ACCSRCUS
| Q4 25 | $-576.0K | $-106.0M | ||
| Q3 25 | $-45.0K | $-135.0M | ||
| Q2 25 | $-475.0K | $0 | ||
| Q1 25 | $5.4M | $-112.0M | ||
| Q4 24 | $-10.2M | $-94.0M | ||
| Q3 24 | $-466.0K | $-92.0M | ||
| Q2 24 | $7.0K | $-93.0M | ||
| Q1 24 | $-139.0K | $-4.0M |
毛利率ACCSRCUS
| Q4 25 | 77.4% | — | ||
| Q3 25 | 74.6% | — | ||
| Q2 25 | 76.2% | — | ||
| Q1 25 | 78.0% | — | ||
| Q4 24 | 75.2% | — | ||
| Q3 24 | 75.0% | — | ||
| Q2 24 | 77.2% | — | ||
| Q1 24 | 75.1% | — |
营业利润率ACCSRCUS
| Q4 25 | -13.1% | -1036.4% | ||
| Q3 25 | -3.2% | -2366.7% | ||
| Q2 25 | -4.4% | -100.0% | ||
| Q1 25 | -12.4% | -1525.0% | ||
| Q4 24 | -245.8% | -447.8% | ||
| Q3 24 | -10.7% | -1500.0% | ||
| Q2 24 | -8.8% | -963.6% | ||
| Q1 24 | -15.5% | -160.0% |
净利率ACCSRCUS
| Q4 25 | -9.9% | -963.6% | ||
| Q3 25 | -0.8% | -2250.0% | ||
| Q2 25 | -8.5% | — | ||
| Q1 25 | 98.4% | -1400.0% | ||
| Q4 24 | -175.0% | -408.7% | ||
| Q3 24 | -8.3% | -1314.3% | ||
| Q2 24 | 0.1% | -845.5% | ||
| Q1 24 | -2.5% | -40.0% |
每股收益（稀释后）ACCSRCUS
| Q4 25 | $-0.16 | $-0.88 | ||
| Q3 25 | $-0.01 | $-1.27 | ||
| Q2 25 | $-0.12 | $0.00 | ||
| Q1 25 | $1.40 | $-1.14 | ||
| Q4 24 | $-2.66 | $-1.07 | ||
| Q3 24 | $-0.12 | $-1.00 | ||
| Q2 24 | $0.00 | $-1.02 | ||
| Q1 24 | $-0.04 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.0M | $222.0M |
| 总债务越低越好 | — | $99.0M |
| 股东权益账面价值 | $30.3M | $631.0M |
| 总资产 | $42.0M | $1.1B |
| 负债/权益比越低杠杆越低 | — | 0.16× |
8季度趋势，按日历期对齐
现金及短期投资ACCSRCUS
| Q4 25 | $3.0M | $222.0M | ||
| Q3 25 | $3.3M | $238.0M | ||
| Q2 25 | — | $248.0M | ||
| Q1 25 | — | $192.0M | ||
| Q4 24 | $4.1M | $150.0M | ||
| Q3 24 | — | $201.0M | ||
| Q2 24 | — | $156.0M | ||
| Q1 24 | — | $185.0M |
总债务ACCSRCUS
| Q4 25 | — | $99.0M | ||
| Q3 25 | — | $98.0M | ||
| Q2 25 | — | $97.0M | ||
| Q1 25 | — | $48.0M | ||
| Q4 24 | — | $48.0M | ||
| Q3 24 | — | $47.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ACCSRCUS
| Q4 25 | $30.3M | $631.0M | ||
| Q3 25 | $30.8M | $436.0M | ||
| Q2 25 | $30.7M | $549.0M | ||
| Q1 25 | $30.9M | $531.0M | ||
| Q4 24 | $25.2M | $485.0M | ||
| Q3 24 | $35.3M | $565.0M | ||
| Q2 24 | $35.4M | $635.0M | ||
| Q1 24 | $35.2M | $707.0M |
总资产ACCSRCUS
| Q4 25 | $42.0M | $1.1B | ||
| Q3 25 | $44.0M | $974.0M | ||
| Q2 25 | $45.6M | $1.1B | ||
| Q1 25 | $47.3M | $1.2B | ||
| Q4 24 | $50.6M | $1.1B | ||
| Q3 24 | $61.7M | $1.3B | ||
| Q2 24 | $62.8M | $1.2B | ||
| Q1 24 | $64.4M | $1.3B |
负债/权益比ACCSRCUS
| Q4 25 | — | 0.16× | ||
| Q3 25 | — | 0.22× | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | 0.10× | ||
| Q3 24 | — | 0.08× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $258.0K | $-120.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-121.0M |
| 自由现金流率自由现金流/营收 | — | -1100.0% |
| 资本支出强度资本支出/营收 | 0.0% | 9.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ACCSRCUS
| Q4 25 | $258.0K | $-120.0M | ||
| Q3 25 | $-582.0K | $-97.0M | ||
| Q2 25 | $135.0K | $-133.0M | ||
| Q1 25 | $747.0K | $-132.0M | ||
| Q4 24 | $866.0K | $-100.0M | ||
| Q3 24 | $1.5M | $26.0M | ||
| Q2 24 | $-190.0K | $-94.0M | ||
| Q1 24 | $986.0K | $-2.0M |
自由现金流ACCSRCUS
| Q4 25 | — | $-121.0M | ||
| Q3 25 | $-590.0K | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $735.0K | $-133.0M | ||
| Q4 24 | — | $-101.0M | ||
| Q3 24 | $1.5M | $25.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | $970.0K | $-6.0M |
自由现金流率ACCSRCUS
| Q4 25 | — | -1100.0% | ||
| Q3 25 | -10.3% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 13.4% | -1662.5% | ||
| Q4 24 | — | -439.1% | ||
| Q3 24 | 26.5% | 357.1% | ||
| Q2 24 | — | — | ||
| Q1 24 | 17.4% | -60.0% |
资本支出强度ACCSRCUS
| Q4 25 | 0.0% | 9.1% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | 0.0% | 0.0% | ||
| Q1 25 | 0.2% | 12.5% | ||
| Q4 24 | 0.0% | 4.3% | ||
| Q3 24 | 0.1% | 14.3% | ||
| Q2 24 | 0.0% | 0.0% | ||
| Q1 24 | 0.3% | 40.0% |
现金转化率ACCSRCUS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -27.14× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACCS
| Cost To Deliver Products | $3.1M | 54% |
| Employee Costs | $1.7M | 29% |
| Other | $1.0M | 17% |
RCUS
| Other | $5.0M | 45% |
| Other Collaboration Revenue | $4.0M | 36% |
| Access Rights And Option Continuation Periods | $2.0M | 18% |
